No 03 2025

Denmark’s recent regulatory moves are increasingly described as a competitive advantage for the country’s life science sector, as the government aligns national rules with the EU Pharmaceutical Package and the forthcoming Biotech Act, according to analysis from Pharmadanmark and EU policy commentators.

When Cancer Crosslinks took place in Oslo on January 22, it marked the meeting’s 18th anniversary. It’s “really coming of age,” jokes Jutta Heix, the Head of International Affairs at Oslo Cancer Cluster, which organizes the meeting.

Cereno Scientific is broadening the development focus of its HDAC inhibitor CS014 to pulmonary hypertension associated with interstitial lung disease (PH-ILD).

Sweden’s updated “samverkansregler” governing collaboration between healthcare and industry took effect on 1 February 2026, following a revised national agreement between SKR (Swedish Association of Local Authorities and Regions) and the trade organisations Lif, Swedish Medtech, SwedenBIO and Swedish Labtech.

The company is initiating additional preclinical studies within its influenza program, with a focus on pandemic avian influenza.

A Swedish–Norwegian research team has identified blood-based biomarkers that could flag Parkinson’s disease up to two decades before classic motor symptoms appear.

Researchers at the University of Gothenburg have developed a new class of boron–fluorine compounds that could make late‑stage optimisation of drugs and imaging agents both simpler and more sustainable. The work, published in Angewandte Chemie, introduces stable “BF₂‑boracycles” that can be made metal‑free, at scale, and without time‑consuming purification – yet remain highly reactive in […]